The University of Pittsburgh has been awarded a $1,572,933 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant's objective is to research "TARGETING LYSOSOMAL PATHWAYS TO IMPROVE HOST IMMUNITY POST CORONAVIRAL INFECTIONS", with a performance period from January 1, 2025 to December 31, 2028. As a state-related research university with significant federal funding, the University of Pittsburgh will leverage its extensive biomedical research capabilities to conduct this innovative study aimed at improving host immunity following coronavirus infections. The funding will support the university's investigation of lysosomal pathways and their potential to enhance immune responses after viral exposure.
Generated 2/25/25, 3:41 AM